SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as the FDA moves to block compounded versions of popular GLP-1 weight-loss drugs, a significant catalyst that strengthens the brand dominance of official products like Wegovy and Ozempic. The community is actively discussing this regulatory shift, with many investors anticipating that the reduced competition will accelerate adoption, boost market share, and act as a tailwind heading into the upcoming earnings report.

Everspin Technologies, Inc. engages in the provision of magnetoresistive random access memory (MRAM) solutions. Its products include Toggle MRAM, Spin-transfer Torque MRAM, TMR Sensors, and Embedded MRAM. The company was founded by Saied Tehrani on May 16, 2008 and is headquartered in Chandler, AZ.

Everspin Technologies Inc

Everspin Technologies is seeing intense momentum fueled by a fresh defense contract and broader investor interest in memory hardware for AI and data centers. The community is actively debating the potential for a short squeeze, balancing excitement over the company's patented technology and military-grade applications against concerns regarding high valuations and pending legal issues.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is seeing heightened trading volume and speculative momentum as investors rotate back into Japanese blockchain projects and IoT-focused assets. While community sentiment remains polarized between long-term holders citing ecosystem expansion and skeptics highlighting a lack of official partnership news, traders are closely monitoring technical breakouts and exchange accumulation trends.

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

Investors are actively debating the future of CRO, with community sentiment split between frustration over persistent token dilution and optimism regarding potential ETF filings and mobile app developments. While some participants are aggressively accumulating, others remain wary, highlighting concerns over management transparency and historical underperformance relative to broader market gains.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is trending following a corporate update regarding financial results and the company's progress toward a pivotal Phase 3 clinical trial for its lead candidate, CAD-1005, aimed at treating heparin-induced thrombocytopenia. While some community members are optimistic about the upcoming trial registration path and orphan drug designations, others are expressing skepticism, focusing on potential share dilution and concerns over aggressive social media promotion.

Investment Managers Series Trust II - Tradr 2X Short SNDK Daily ETF

Tradr 2X Short SNDK Daily ETF

Tradr 2X Short SNDK Daily ETF (SNDQ) is seeing significant volume and trader attention as market participants attempt to hedge against the rapid, parabolic price appreciation in SanDisk (SNDK). The community is actively debating the sustainability of the semiconductor sector's momentum, with many users employing SNDQ as a tactical vehicle to bet on a potential correction or reversal.

Roundhill ETF Trust - Roundhill Memory ETF

Investors are flooding into the Roundhill Memory ETF (DRAM) as the memory sector experiences a supply crunch driven by the insatiable AI demand for High-Bandwidth Memory and NAND flash. The community is actively discussing this thematic capital rotation, with many viewing the stock as a strategic way to gain diversified exposure to the essential infrastructure powering the ongoing AI boom.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta (KTA) is trending as community members aggressively debate its long-term potential as a high-speed institutional settlement layer, often citing its reported partnership history and infrastructure capabilities. The discussion is heavily polarized between bullish investors highlighting its 11M TPS architecture and potential fintech use cases versus skeptics who dismiss the activity as repetitive spam or an unproven pump-and-dump scheme.

monday.com Ltd. engages in the business of operating a cloud-based visual work operating system that consists of modular building blocks that can be easily used and assembled to create software applications and work management tools and serves as a connective layer to integrate with various digital tools across an organization. It operates through the following geographical segments: United States, EMEA, United Kingdom, and Rest of the World. The company was founded by Roy Mann, Eran Kampf, and Eran Zinman in 2012 and is headquartered in Tel Aviv, Israel.

Monday.Com Ltd

Monday.com Ltd

Monday.com is currently facing significant volatility as investors weigh strong quarterly revenue and earnings beats against concerns over lowered forward guidance and broader fears that AI agents could disrupt the traditional SaaS business model. The community remains deeply divided, with some investors aggressively buying the dip due to the company's strong cash position and growth metrics, while others warn of potential further downside fueled by intense short-selling pressure and skepticism regarding long-term software viability in an AI-native market.

The Ondo Foundation was founded in 2022 as an independently governed and nonprofit Cayman Islands Foundation Company with no beneficial owners. The Ondo Foundation assisted in the launch of the Ondo DAO, which deployed and currently governs Flux Finance, the first lending protocol supporting tokenized securities as collateral.  ONDO token holders are entrusted with shaping the future of the Ondo DAO so that it continues to pursue its mission to democratize access to institutional-grade finance. The Ondo DAO gives ONDO holders specific rights pertaining to Flux Finance, which is currently governed by the Ondo DAO.

Ondo

Ondo is trending as investors focus on its leading role in the real-world asset (RWA) sector and its strategic partnerships with major financial institutions. Community sentiment remains divided between long-term confidence in its institutional utility and frustration regarding recent price volatility and upcoming token unlocks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Co-Diagnostics Joint Venture CoMira Finalizes Lease Agreement for Manufacturing Facility in Saudi Arabia's Sudair Industrial City

Co-Diagnostics Joint Venture CoMira Finalizes Lease Agreement for Manufacturing Facility in Saudi Arabia's Sudair Industrial City Co-Diagnostics Joint Venture CoMira Finalizes Lease Agreement for...

GoodRx Holdings, Inc. (GDRX) Q1 Earnings Match Estimates

GoodRx (GDRX) delivered earnings and revenue surprises of -5.41% and +7.73%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Co-Diagnostics Announces First Quarter 2026 Earnings Release Date and Webcast

Co-Diagnostics Announces First Quarter 2026 Earnings Release Date and Webcast Co-Diagnostics Announces First Quarter 2026 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY, April 30, 2026...

Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C.

Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C. Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C. PR Newswire SALT LAKE CITY...

Co-Diagnostics to Showcase Co-Dx PCR Platform and CE-IVD Solutions at ESCMID 2026 in Munich, Germany

Co-Diagnostics to Showcase Co-Dx PCR Platform and CE-IVD Solutions at ESCMID 2026 in Munich, Germany Co-Diagnostics to Showcase Co-Dx PCR Platform and CE-IVD Solutions at ESCMID 2026 in Munich...

Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah

Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah...

Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia's Sudair Industrial City

Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia's Sudair Industrial City Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia's Sudair Industrial City PR Newswire SALT LAKE CITY, April...

 This Diagnostics Company Is Advancing a Global Expansion Strategy, Positioning for Growth Phase

The molecular diagnostics sector continues to evolve as companies shift focus from pandemic-driven demand toward broader infectious disease testing, global distribution networks, and next-generation platforms powered by artificial intelligence. As regulatory pathways reopen and international markets expand, companies with scalable, adaptable technologies are working to reposition themselves for long-term growth.Shares of Co-Diagnostics, Inc. (NASDAQ: CODX) finished Tuesday higher after the company reported its full-year 2025 financial results and outlined progress across its global ...

Co-Diagnostics Reports Full Year 2025 Financial Results

Co-Diagnostics Reports Full Year 2025 Financial Results Co-Diagnostics Reports Full Year 2025 Financial Results PR Newswire SALT LAKE CITY, March 31, 2026 Advancing Global Commercialization Strategy...

Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.

Co-Diagnostics Inc

Up > 1%

Flat +/- 1%

Down > 1%

Where does the $SPY finish next week vs. Friday’s close?

CODX
Co-Diagnostics Inc

Feed

News

Sentiment

Fundamentals

Info

Compact View

Poll

Latest CODX News

CODXCo-Diagnostics Inc